Search Results - "MAJOR, Amy S"

Refine Results
  1. 1

    How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses by Rhoads, Jillian P, Major, Amy S

    Published in Critical reviews in immunology (2018)
    “…Cardiovascular disease (CVD) is the number one cause of death in the United States and worldwide. The most common cause of cardiovascular disease is…”
    Get full text
    Journal Article
  2. 2

    Fine tuning of immunometabolism for the treatment of rheumatic diseases by Rhoads, Jillian P., Major, Amy S., Rathmell, Jeffrey C.

    Published in Nature reviews. Rheumatology (01-05-2017)
    “…The pathways by which cells modulate metabolism to attain optimal effector responses present numerous potential therapeutic targets in the context of rheumatic…”
    Get full text
    Journal Article
  3. 3

    Local effects of human PCSK9 on the atherosclerotic lesion by Giunzioni, Ilaria, Tavori, Hagai, Covarrubias, Roman, Major, Amy S, Ding, Lei, Zhang, Youmin, DeVay, Rachel M, Hong, Liang, Fan, Daping, Predazzi, Irene M, Rashid, Shirya, Linton, MacRae F, Fazio, Sergio

    Published in The Journal of pathology (01-01-2016)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes atherosclerosis by increasing low‐density lipoprotein (LDL) cholesterol levels through…”
    Get full text
    Journal Article
  4. 4

    Deletion of Macrophage LDL Receptor–Related Protein Increases Atherogenesis in the Mouse by Overton, Cheryl D, Yancey, Patricia G, Major, Amy S, Linton, MacRae F, Fazio, Sergio

    Published in Circulation research (16-03-2007)
    “…Macrophage low-density lipoprotein receptor–related protein (LRP) mediates internalization of remnant lipoproteins, and it is generally thought that blocking…”
    Get full text
    Journal Article
  5. 5
  6. 6

    B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice by Major, Amy S, Fazio, Sergio, Linton, MacRae F

    “…OBJECTIVE—Atherosclerosis is an inflammatory disease characterized by innate and adaptive immune responses. We investigated the role of B cells and antibodies…”
    Get full text
    Journal Article
  7. 7

    Specific deletion of LDL receptor-related protein on macrophages has skewed in vivo effects on cytokine production by invariant natural killer T cells by Covarrubias, Roman, Wilhelm, Ashley J, Major, Amy S

    Published in PloS one (22-07-2014)
    “…Expression of molecules involved in lipid homeostasis such as the low density lipoprotein receptor (LDLr) on antigen presenting cells (APCs) has been shown to…”
    Get full text
    Journal Article
  8. 8

    Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity by Ma, Li-Jun, Corsa, Bridgette A, Zhou, Jun, Yang, HaiChun, Li, HaiJing, Tang, Yi-Wei, Babaev, Vladimir R, Major, Amy S, Linton, MacRae F, Fazio, Sergio, Hunley, Tracy E, Kon, Valentina, Fogo, Agnes B

    “…The mechanisms for increased risk of chronic kidney disease (CKD) in obesity remain unclear. The renin-angiotensin system is implicated in the pathogenesis of…”
    Get more information
    Journal Article
  9. 9

    Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice by Wilson, Christopher S, Stocks, Blair T, Hoopes, Emilee M, Rhoads, Jillian P, McNew, Kelsey L, Major, Amy S, Moore, Daniel J

    Published in JCI insight (08-10-2021)
    “…Autoimmune disease has presented an insurmountable barrier to restoration of durable immune tolerance. Previous studies indicate that chronic therapy with…”
    Get full text
    Journal Article
  10. 10

    Bone marrow deficiency of MCPIP1 results in severe multi-organ inflammation but diminishes atherogenesis in hyperlipidemic mice by Yu, Fang, Du, Fen, Wang, Yuzhen, Huang, Shengping, Miao, Ruidong, Major, Amy S, Murphy, E Angela, Fu, Mingui, Fan, Daping

    Published in PloS one (06-11-2013)
    “…MCPIP1 is a newly identified protein that profoundly impacts immunity and inflammation. We aim to test if MCPIP1 deficiency in hematopoietic cells results in…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E–Deficient Mice by Major, Amy S, Wilson, Michael T, McCaleb, Jennifer L, Su, Yan Ru, Stanic, Aleksandar K, Joyce, Sebastian, Van Kaer, Luc, Fazio, Sergio, Linton, MacRae F

    “…BACKGROUND—Atherosclerosis is a disease marked by lipid accumulation and inflammation. Recently, atherosclerosis has gained recognition as an autoimmune-type…”
    Get full text
    Journal Article
  14. 14

    The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy by Appleton, Brenna D., Major, Amy S.

    Published in Current opinion in rheumatology (01-03-2021)
    “…Accelerated atherosclerosis is a significant comorbidity and the leading cause of death for patients with systemic lupus erythematosus (SLE). It is now…”
    Get full text
    Journal Article
  15. 15

    Immune Dysregulation Accelerates Atherosclerosis and Modulates Plaque Composition in Systemic Lupus Erythematosus by Stanic, Aleksandar K., Stein, Charles M., Morgan, Adam C., Fazio, Sergio, Linton, MacRae F., Wakeland, Edward K., Olsen, Nancy J., Major, Amy S.

    “…Patients with systemic lupus erythematosus (SLE) have accelerated atherosclerosis. The underlying mechanisms are poorly understood, and investigations have…”
    Get full text
    Journal Article
  16. 16

    FcγRIIb on CD11c+ cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr−/− mice by Marvin, Jennifer, Rhoads, Jillian P., Major, Amy S.

    Published in Atherosclerosis (01-06-2019)
    “…Circulating levels of oxidized lipoprotein (oxLDL) correlate with myocardial infarction risk and atherosclerosis severity. Our previous study demonstrates that…”
    Get full text
    Journal Article
  17. 17

    Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1 by YAN RU SU, DOVE, Dwayne E, MAJOR, Amy S, HASTY, Alyssa H, BOONE, Branden, LINTON, Macrae F, FAZIO, Sergio

    Published in Circulation (New York, N.Y.) (10-05-2005)
    “…Macrophage acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1) and apolipoprotein E (apoE) have been implicated in regulating cellular cholesterol…”
    Get full text
    Journal Article
  18. 18

    Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9 by Rhoads, Jillian P, Lukens, John R, Wilhelm, Ashley J, Moore, Jared L, Mendez-Fernandez, Yanice, Kanneganti, Thirumala-Devi, Major, Amy S

    Published in The Journal of immunology (1950) (01-03-2017)
    “…Oxidized low-density lipoprotein (oxLDL) is known to activate inflammatory responses in a variety of cells, especially macrophages and dendritic cells…”
    Get full text
    Journal Article
  19. 19

    Oxidized Phospholipid oxPAPC Alters Regulatory T-Cell Differentiation and Decreases Their Protective Function in Atherosclerosis in Mice by Appleton, Brenna D, Palmer, Sydney A, Smith, Harrison P, Stephens, Lilly E, Major, Amy S

    “…Regulatory T cells (T ) are protective in atherosclerosis but reduced during disease progression due to cell death and loss of stability. However, the…”
    Get full text
    Journal Article
  20. 20

    Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice by Wilhelm, Ashley J, Rhoads, Jillian P, Wade, Nekeithia S, Major, Amy S

    Published in Annals of the rheumatic diseases (01-04-2015)
    “…Accelerated atherosclerosis is a major source of morbidity in systemic lupus erythematosus (SLE). However, the cause of SLE-accelerated atherosclerosis remains…”
    Get more information
    Journal Article